BRIEF-Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation System

Reuters
17 Apr
BRIEF-Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation System

April 17 (Reuters) - Adagio Medical Holdings Inc ADGM.O:

  • ADAGIO MEDICAL HOLDINGS, INC. RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR THE VCLASTM CRYOABLATION SYSTEM

Source text: ID:nBw5XftzMa

Further company coverage: ADGM.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10